title: Expression of thymidine phosphorylase in human superficial bladder cancer.
abstract: BACKGROUND
  The purpose of the present paper was to investigate the expression level of thymidine phosphorylase (TPase) in superficial bladder cancer tissues obtained by transurethral resection, and determine whether its expression correlates with tumor recurrence.
  
  
  METHODS
  From March 1998 to December 2001, 99 patients with superficial bladder cancer were diagnosed and treated at eight affiliated hospitals. Tissue specimens obtained by transurethral resection of superficial bladder cancer (TURBT) were applied to immunohistochemical study using anti-TPase antibody as well as pathological diagnosis. The data were subjected to statistical analysis.
  
  
  RESULTS
  Using MoAb 654-1 as the primary antibody, TPase was clearly stained in human bladder cancer tissues. The maximum TPase level measured by enzyme-linked immunosorbent assay (ELISA) method in normal bladder tissues was 18.7 U/mg protein. The TPase activity was 2.8-fold higher in tumors than in normal bladder samples (P = 0.037). The TPase positivity rates determined by immunohistochemical and ELISA methods were distinctly correlated (P = 0.046). For the recurrence-free rates in pT1 tumors treated by TURBT alone (n = 46), there were no statistically significant differences between Tpase-positive or -negative cases.
  
  
  CONCLUSIONS
  The TPase expression determined by ELISA and immunohistochemistry is significantly up-regulated in superficial bladder tumors compared with normal bladder samples. However, TPase expression by immunohistochemistry is not a predictive index of recurrence-free rate for superficial bladder cancer treated with TURBT alone.
authors.affiliation: Department of Urology, Ube Industries Central Hospital, Ube, Japan. shimaube@siren.ocn.ne.jp
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Shimabukuro
authors.forename: Hideyasu
authors.initials: H
authors.lastname: Matsuyama
authors.forename: Yoshikazu
authors.initials: Y
authors.lastname: Baba
authors.forename: Kazutaka
authors.initials: K
authors.lastname: Jojima
authors.forename: Ken-Ichi
authors.initials: K
authors.lastname: Suyama
authors.forename: Akihiko
authors.initials: A
authors.lastname: Aoki
authors.forename: Akinobu
authors.initials: A
authors.lastname: Suga
authors.forename: Norio
authors.initials: N
authors.lastname: Yamamoto
authors.forename: Katsusuke
authors.initials: K
authors.lastname: Naito
mesh_terms: D000368:Aged; D002295:Carcinoma, Transitional Cell / Q000201:enzymology / Q000601:surgery; D018572:Disease-Free Survival; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D013194:Staining and Labeling; D013939:Thymidine Phosphorylase / Q000378:metabolism*; D015854:Up-Regulation; D001749:Urinary Bladder Neoplasms / Q000201:enzymology* / Q000601:surgery
chemical_list: D013939:Thymidine Phosphorylase